We’re all aware of the biggest names in the cannabis industry right now. Companies like Canopy Growth, Aphria, Tilray, Cronos Group, and Aurora Cannabis are all mentioned when we see reports about “Market Leaders” in marijuana.
The interesting part: there may be the other companies out there that could be built on a much more streamlined platform and could offer almost immediate access to the market potential ahead…
Building A Company Just Takes “Patients”
Canopy Growth reported 84,400 registered patients at September 30, 2016. In its latest financial report, Aurora Cannabis reported that it had 67,484 active registered patients and this was up from roughly 43,000 during the prior quarter.
Meanwhile you have funds like Vanguard Total Intl Stock Idx Fund, Golden Opportunities Diversified, Vanguard Developed Markets Index Fund, Vanguard FTSE All-Wld ex-US SmCp Idx Fd, iShares Core S&P/TSX Capped Compost ETF, and the two cannabis industry ETFs: Horizons Marijuana Life Sciences ETF & ETFMG Alternative Harvest ETF among others, holding more than a cumulative 40 million shares of Aurora in their portfolios (1).
But what if you found out that there’s another company out there that not only has over 100,000 patients (compared to Aurora’s at less than 70,000 or Canopy with just over 80,000) but also has built a diversified business model (like Aurora) targeting both the traditional healthcare market in addition to legal cannabis?
Also, in comparison to Aurora’s $5.70+ per share price tag, the company we’re talking about is trading around 1/10th of that figure.
New Connect The Dots Featured Company: Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI)
Premier is developing innovative healthcare approaches that combine human skill-based expertise with emerging technologies. Where the cannabis industry could come into play is with the company subsidiary HealthVue and its list of patients over 100,000 strong…that’s right…more than one hundred thousand ACTIVE patients.
Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has engaged discussions with Licensed Producers under the Access to Cannabis for Medical Purposes Regulation (ACMPR), other licensed medical cannabis companies and government officials in order to establish a framework for both patient and physician education. The company’s CEO said it perfectly:
“With over 110,000 active patients in our clinic ecosystem, it is important that we provide them with the best possible information that allows them to make informed decisions about their personal and family’s health. Providing our family physicians with the appropriate tools and knowledge to prescribe cannabis or with the ability to refer patients to a specialist within our clinics is a key outcome of this initiative.”
-Dr. Essam Hamza, CEO of Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI)
Canadian Market Could Offer Opportunity For Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI)
1. The Canadian retail pharmacy market is estimated to be $44 billion (Source: IBISWorld). It is expected the industry sector will continue to allow for favorable economics for pharmacy operators as baby boomer’s demand increases for prescriptions and operators to expand the scope of practice to include preventative services.
2. The Canadian medical cannabis clinic market is estimated to be worth approximately $2.35 billion by 2025.
If these two facts weren’t enough, there is also a MAJOR Cross Over in Canada that connects medical cannabis & retail pharmacies. For some reason, news outlets aren’t paying attention to it right now either.
The crossover: Canadian pharmacies are fully behind medical marijuana too! Shoppers, Lovell Drugs and PharmaChoice have all signed supply deals with leading cannabis producers in Canada. Their pending entry into the medical cannabis market comes as the number of registered MMJ patients is soaring.
Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could have an ideal business model in progress that would vertically integrate cannabis as another growth opportunity. Also, consider that industry peers like Aurora Cannabis don’t hold a flame to the number of active patients that Premier Health Group has and the numbers could really start to make a lot more sense once eyes begin to open on the street.
Just The Tip Of The Iceberg For Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI)
Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has much more in the works and as we discussed earlier, the company is building a diversified model. Managing health and wellbeing is a full-time responsibility. With yearly physicals, vaccinations, and those few days out of the year where you don’t feel 100%, a reliable source of primary care is vital to both physical and mental health.
Finding primary care can be challenging, especially in countries like Canada, where shortages in available primary care physicians and nurses make it more difficult to find available appointments. The doctors that end up having availability get blitzed with a barrage of patients and burnout.
More likely than not, healthcare companies won’t be able to solve every issue facing their industry, but that doesn’t mean companies aren’t finding innovative ways to help their patients access primary care. For this reason, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has also focused on traditional care in addition to its cannabis-related operations.
HealthVue, a subsidiary of Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI), is focused on redesigning how medical care is received. Premier’s objective is to develop new technologies that deliver the best quality healthcare possible, through the seamless combination of their network of primary care clinics with telemedicine and artificial intelligence. With an elite team of industry leaders, knowledgeable physicians, and specialists at the top of their fields, HealthVue is on the precipice of becoming the authority on accessible primary care.
This area of healthcare is on fire right now, and the heat is only intensifying. According to Reuters, the deployment of telemedicine has significantly altered the healthcare paradigm, due to the many technological advancements in the field of medical devices and services. With the geriatric population increasing every day, paired with “rising prevalence of chronic diseases, the dearth of healthcare professionals worldwide,” these are just some factors expected to catalyze the growth of the telemedicine market.
On October 11, 2018, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) announced their selection of Reliq Health Technologies Inc. as its exclusive technology partner. Reliq is “a healthcare technology company that specializes in developing innovative software as a service solution for the $30 billion community carer market.” Reliq’s mission, like their new partner Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI), is to create technological solutions to “allow patients to receive high-quality care in the home or other community-based settings, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.”
“We are very excited to be selected by Premier Health Group as the exclusive technology partner for their HealthVue Clinics. We look forward to helping HealthVue establish themselves as a technology leader in primary care.”
- Lisa Crossley CEO, Reliq Health Technologies Inc.
Pursuant to this selection, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) will look to Reliq to further HealthVue’s telemedicine system by incorporating their technology platform to power the HealthVue patient app. The HealthVue app, powered by Reliq, “will allow patients to book appointments, see their GP or specials, review their own chart, chat with clinic staff and pharmacists, refill prescriptions and share health data collected in the home with their HealthVue care team,” said Dr. Essam Hamza, MD, CEO of HealthVue.
Premier Health is taking a strategic approach to the market, and ensuring that it can meet the demands of consumers, by collaborating with Reliq. Premier Health recognizes new market demands and is prepared to meet them by developing the technology component of their practice, in partnership with Reliq.
Reliq’s mobile platform, designed to adapt to meet the expectations of patients, offers a more mature solution compared to others and has a first mover advantage with reset to targeting LTC and home care providers. Reliq, in collaboration with Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI), will have greater access to the patient population for its enterprise customers.
Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) Announces First Pharmacy Acquisition LOI
As a part of its growth strategy to cover the major verticals associated with primary care, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has JUST signed a binding Letter of Intent to acquire a Vancouver, British Columbia based pharmacy. And the expected closing isn’t years away, the Company expects the acquisition to close in or about Q1-19!
For the fiscal year 2017/18, the pharmacy has revenues of approximately $1MM and Adjusted EBITDA1 of approximately 30%. “We are excited for this opportunity to acquire our first pharmacy, and thereafter being able to prepare and deliver prescription and non-prescription pharmaceuticals and other health products to patients. In doing so, the pharmacist will play an integral role in our team-based patient-centric model,” said Dr. Essam Hamza, CEO of Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI).
In our opinion, this is much more than just an opportunity to sell prescriptions. Look at what the pharmacy industry in Canada is experiencing RIGHT NOW:
Shoppers Drug Mart has been granted a license to sell medical marijuana online.
Health Canada’s list of authorized cannabis sellers and producers has been updated to reflect that the pharmacy can sell dried and fresh cannabis, as well as plants, seeds, and oil.
A website has been set up by the company, which says that patients “with a valid medical document will soon be able to purchase a wide selection of medical cannabis products” from Shoppers.
The spectrum of offerings has just been widened and those companies getting a foot in the Canadian pharmacy market right now could have the upper hand as this market continues to expand. Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) not only has a large patient pool and a “foot in the door” with this LOI, but they’ve also got telehealth technology in place to stay at the forefront of this new market directive!
The long and short of it is that Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has built a HUGE pool of patients that essentially dwarfs that of some of the “market leaders” in cannabis as we know it. With a multifaceted strategy to tap into Canada’s health sector and the direct cross over into its booming cannabis industry, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could be positioned to take immediate advantage to monetize its patient pool.
Recent reports show that nearly 15% of Canadians aged 12 and older do not have a primary care physician. Additionally, almost 66% of senior citizens in Canada are unable to get same-or next-day appointments.
Telemedicine is one of the fastest growing sectors in the healthcare industry, increasing in size every single day. Recent reports forecast the global Telehealth market reaching $19.5 billion by 2025, according to Transparency Market Research. The surge in demand for convenient primary care, coupled with technological advancements in mobile solutions for healthcare will drive the market forward.
Furthermore, the bigger opportunity could be its focus on the cannabis industry. Again, just an opinion but when you compare the two, though Aurora is (finally) generating revenue, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is still in the early stages of growth yet already has access to a pool of patients that is more than 50% larger in size than Aurora and more than 15% to that of Canopy.
It may all come down to the timing of it all especially considering the latest news that Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) just released. As healthcare takes a center stage position during the latest bout of market volatility and cannabis legalization remains a focus of funds looking for the next “star” to shine, could Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) be at the right place & at the right time?
(1) As of Tue 27/11/2018 According to Morningstar http://quote.morningstar.ca/Quicktakes/owners/MajorShareholders.aspx?t=ACB®ion=CAN&culture=en-CA
DISCLAIMER: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), MIDAM VENTURES, LLC and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam was paid $100,000 (CASH) for & were paid “500,000” shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the “500,000” shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. FULL DISCLAIMER HERE